Evidence map›Paper›PMID 37484752›Full record

ArticleClinical case reports2023

Loss of TSC1 in secondary angiosarcoma of the breast.

Lucy Rose, Nicci Owusu-Brackett, Stephen Moore, Bridget Oppong

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lucy RoseDivision of Surgical Oncology, Department of Surgery The Ohio State University Wexner Medical Center Columbus Ohio USA.ORCID https://orcid.org/0000-0002-2741-3951
Nicci Owusu-BrackettDivision of Surgical Oncology, Department of Surgery The Ohio State University Wexner Medical Center Columbus Ohio USA.ORCID https://orcid.org/0000-0002-5409-2583
Stephen MooreDepartment of Pathology The Ohio State University Wexner Medical Center Columbus Ohio USA.
Bridget OppongDivision of Surgical Oncology, Department of Surgery The Ohio State University Wexner Medical Center Columbus Ohio USA.ORCID https://orcid.org/0000-0002-1696-4491
The Ohio State University Wexner Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Post-radiation angiosarcoma of the breast is a rare complication associated with a poor prognosis. This case reports the first loss of function mutation in TSC1 in breast radiation-induced angiosarcoma and illustrates the utility of evaluating these markers to identify potential therapeutic targets. Abstract: Post-radiation angiosarcoma of the breast is rare and associated with a poor prognosis. This case presents the first loss of function mutation in TSC1 in breast radiation-induced angiosarcoma. Evaluation of these markers can aid in identifying potential therapeutic targets.

Indexed as

breast cancermTOR inhibitorsnab‐sirolimusradiationradiation‐induced angiosarcomaTSC1 mutation

Identifiers

PMID37484752
PMCPMC10357003
OpenAlexW4384937722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.